DK2908831T3 - Urteformuleringer - Google Patents
Urteformuleringer Download PDFInfo
- Publication number
- DK2908831T3 DK2908831T3 DK13786441.9T DK13786441T DK2908831T3 DK 2908831 T3 DK2908831 T3 DK 2908831T3 DK 13786441 T DK13786441 T DK 13786441T DK 2908831 T3 DK2908831 T3 DK 2908831T3
- Authority
- DK
- Denmark
- Prior art keywords
- formulation
- extract
- propolis
- zingiber officinale
- formulations
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
- A61K35/644—Beeswax; Propolis; Royal jelly; Honey
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Insects & Arthropods (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Animal Husbandry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Claims (16)
1. En formulering bestående af Propolis-ekstrakt, Ginseng-ekstrakt og Zingiber officinale-ekstrakt, idet - den procentvise mængde af Zingiber officinale-ekstrakten baseret på den samlede formuleringsvolumen er mindre end 30% (w/v), foretrukket mindre end 15% (w/v), og særligt foretrukket mellem 0,2% og 5% (w/v), - den procentvise mængde af Propolis-ekstrakten baseret på den samlede formuleringsvolumen er mellem 0,02% og 30% (w/v), foretrukket mellem 0,02% og 15% (w/v), og særligt foretrukket mellem 0,02% og 5% (w/v), - den procentvise mængde af Ginseng-ekstrakten baseret på den samlede formuleringsvolumen er mellem 0,05% og 60% (w/v), foretrukket mellem 0,05% og 25% (w/v), og særligt foretrukket mellem 0,1 % og 10% (w/v), - og nævnte formulering desuden består af Glycyrrhiza glabra-ekstrakt.
2. Formuleringen ifølge et hvilket som helst af de foregående krav, idet vægtforholdet mellem Glycyrrhiza glabra-ekstrakten og Zingiber officinale-ekstrakten er mellem 50:1 og 1:20, foretrukket mellem 30:1 og 1:10, og særligt foretrukket mellem 20:1 og 1:5.
3. Formuleringen ifølge et hvilket som helst af de foregående krav, idet nævnte formulering administreres ved oral, parenteral, okulær, nasal, bukkal, sublingual og topikal dosering.
4. Formuleringen ifølge krav 3, idet det er foretrukket at administrere denne ved oral dosering.
5. Formuleringen ifølge krav 4, idet denne foretrukket findes i en flydende oral doseringsform, særligt foretrukket i en sirupform.
6. Formuleringen ifølge et hvilket som helst af de foregående krav, som desuden omfatter i det mindste et farmaceutisk anerkendt hjælpestof valgt fra gruppen omfattende fyldstoffer, opløsningsmidler, pH-justerende midler, sødemidler, aromatiske stoffer og konserveringsmidler.
7. Formuleringen ifølge krav 6, idet fyldstoffet vælges fra gruppen omfattende sucrose, sorbitol, xylitol, dextrose, fruktose, maltitol, sukker, kalium, aspartam, sakkarin, natriumsakkarin, spraytørret eller vandfri laktose, mannitol, stivelse, cellulose (foretrukket mikrokrystallinsk cellulose) og blandinger heraf, fyldstoffet er foretrukket sorbitol.
8. Formuleringen ifølge krav 7, idet den procentvise mængde af sorbitol baseret på den samlede formuleringsvolumen er mellem 1% og 60% (w/v), foretrukket mellem 5% og 30% (w/v), og særligt foretrukket mellem 10% og 25% (w/v).
9. Formuleringen ifølge krav 6, idet de pH-justerende midler er valgt fra gruppen omfattende ascorbinsyre, eddikesyre, vinsyre, citronsyre, natriumcitrat, kaliumcitrat, natriumfosfat, tricalciumfosfat, calciumcarbonat, natriumbicarbonat, calciumfosfat, kulsyreholdige calciumfosfater, magnesiumhydroxid og hydrater heraf og blandinger heraf, de pH-justerende midler er foretrukket citronsyremonohydrat og natriumcitratdihydrat.
10. Formuleringen ifølge krav 9, idet vægtforholdet mellem natriumcitratdihydrat og citronsyremonohydrat er 1:2.
11. Formuleringen ifølge krav 6, idet den ikke omfatter konserveringsmidler.
12. Formuleringen ifølge krav 6, idet de aromatiske stoffer er valgt fra gruppen omfattende frugtaromaer såsom af appelsin, kirsebær, jordbær, banan, surkirsebær, citron; aromaer af kardemomme, anis, mynte, mentol, eukalyptus, vanillin og ethylvanillin og blandinger heraf, det aromatiske stof er foretrukket eukalyptus.
13. Formuleringen ifølge krav 12, idet den procentvise mængde af eukalyptus baseret på den samlede formuleringsvolumen er mellem 0,01% og 5% (w/v), foretrukket mellem 0,03% og 3% (w/v), og særligt foretrukket mellem 0,05% og 2%.
14. Formuleringen ifølge krav 6, idet sødemidlerne er valgt fra gruppen omfattende sukralose, ammoniumglycyrrhizinat, acesulfam-K, aspartam, sakkarin eller natrium- og calciumsalte af sakkarin, natriumcyclamat, sucrose, fruktose, glucose, sorbitol og blandinger heraf.
15. Formuleringen ifølge krav 14, idet den procentvise mængde af sødemidlet baseret på den samlede formuleringsvolumen er mellem 0,005% og 20% (w/v), foretrukket mellem 0,005% og 15% (w/v), og særligt foretrukket mellem 0,005% og 10% (w/v).
16. Formuleringen ifølge krav 6, idet opløsningsmidlerne er valgt fra gruppen omfattende vandopløselige polære opløsningsmidler såsom propylenglycol, glycerin, vand, ethanol, isopropylalkohol og vanduopløselige ikke-polære opløsningsmidler eller en blanding heraf.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TR201212042 | 2012-10-17 | ||
TR201212043 | 2012-10-18 | ||
PCT/EP2013/071758 WO2014060533A1 (en) | 2012-10-17 | 2013-10-17 | Herbal formulations |
Publications (1)
Publication Number | Publication Date |
---|---|
DK2908831T3 true DK2908831T3 (da) | 2018-03-12 |
Family
ID=49546384
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK13786441.9T DK2908831T3 (da) | 2012-10-17 | 2013-10-17 | Urteformuleringer |
Country Status (12)
Country | Link |
---|---|
US (1) | US10111912B2 (da) |
EP (1) | EP2908831B1 (da) |
DK (1) | DK2908831T3 (da) |
EA (1) | EA201590571A1 (da) |
ES (1) | ES2661373T3 (da) |
HU (1) | HUE038237T2 (da) |
LT (1) | LT2908831T (da) |
PL (1) | PL2908831T3 (da) |
PT (1) | PT2908831T (da) |
RS (1) | RS56980B1 (da) |
TR (1) | TR201802779T4 (da) |
WO (1) | WO2014060533A1 (da) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9913869B2 (en) | 2012-10-17 | 2018-03-13 | Montero Gida Sanayi Ve Ticaret A.S. | Formulations comprising herbal extracts |
SI2908834T1 (sl) | 2012-10-17 | 2017-12-29 | Montero Gida Sanayi Ve Ticaret A.S. | Nove formulacije, ki obsegajo rastlinske ekstrakte |
WO2014060525A1 (en) | 2012-10-18 | 2014-04-24 | Montero Gida Sanayi Ve Ticaret A.S. | Stable formulations |
CN103977120A (zh) * | 2014-04-28 | 2014-08-13 | 秦文雄 | 治疗扁桃体发炎的清咽润喉含片 |
GR1009175B (el) | 2016-06-13 | 2017-12-18 | Apivita Καλλυντικα Διαιτητικα Φαρμακα Ανωνυμη Εμπορικη Και Βιοτεχνικη Εταιρεια | Συνδυασμος εκχυλισματος μικροφυκους nannochloropsis gaditana και εκχυλισματος προπολης ως δραστικου συστατικου σε καλλυντικοτεχνικες φορμουλες για δερματικη χρηση |
TR201908777A2 (tr) * | 2019-06-13 | 2019-07-22 | Sbs Bilimsel Bio Coezuemler Sanayi Ve Ticaret A S | Suda Çözünür ve Suda Çözünür Olmayan Özellikte Yüksek Antioksidan Kapasitesine Sahip Propolis Ürünleri ve Üretim Yöntemi |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE780165A (en) * | 1972-03-03 | 1972-07-03 | Urbano Antonio | Liq compsn contg extract of mint, pine and eucalyptus - for releiving respiration difficulties |
CH676931A5 (en) | 1988-08-02 | 1991-03-28 | Spagyros S A | Herbal medicaments prodn. - contg. essential antimicrobial oils and Echinacea tinctures, for treating infections, etc. |
DE4211745A1 (de) | 1992-04-03 | 1993-10-07 | Boerner Gmbh | Verwendung von Propolis und/oder seinen Fraktionen |
HUT75540A (en) * | 1993-08-06 | 1997-05-28 | Hegyi | Method for cold dissolution of propolis and one for making chocolate using said solution adding preferably vegetable materials to it |
US5904924A (en) * | 1997-11-04 | 1999-05-18 | Oncologics, Inc. | Green nutritional powder composition |
DE60220958T2 (de) | 2002-12-30 | 2008-04-10 | Council Of Scientific And Industrial Research | Entwicklung einer hustenstillenden und rachenschmerzlindernden formulierung aus kräutern |
EP1520584A1 (en) | 2003-10-01 | 2005-04-06 | Boehringer Ingelheim International GmbH | Composition for the activation of the immune system |
ES2662889T3 (es) | 2006-03-01 | 2018-04-10 | Divapharma Chur Ag | Pastilla para chupar que contiene Pelargonium en combinación con Plantago |
US8653135B1 (en) * | 2007-02-07 | 2014-02-18 | Sovereign Pharmaceuticals, Llc | Alternating sympathomimetic therapy for the treatment of respiratory aliments |
KR20070078753A (ko) * | 2007-05-29 | 2007-08-01 | 박준태 | 알로에와 마늘을 이용한 보건제의 개선된 제조방법. |
KR100896453B1 (ko) | 2007-07-18 | 2009-05-14 | 닥터 빌마르 쉬바베 게엠바하 운트 코 카게 | 페라고늄 시도이데스 시럽 |
JP2011504184A (ja) * | 2007-11-21 | 2011-02-03 | ザ プロクター アンド ギャンブル カンパニー | 咳治療に有用な製剤、方法及びキット |
CN101318937B (zh) * | 2008-06-20 | 2010-11-03 | 广西医科大学 | 一种生物碱类化合物及其制备方法和用途 |
CN101637347A (zh) | 2009-06-16 | 2010-02-03 | 成进学 | 富硒、锗麦饭石的全元素防癌益寿药枕(袋) |
CN101695563A (zh) * | 2009-08-25 | 2010-04-21 | 李永胜 | 一种防治慢性气管炎肺心病的颗粒和散 |
CN102100900A (zh) | 2009-12-16 | 2011-06-22 | 唐莹 | 一种治疗呼吸系统疾病的中药 |
CN102343077A (zh) | 2010-07-28 | 2012-02-08 | 陈登 | 一种治疗支气管炎的中药配方 |
KR101041575B1 (ko) * | 2010-12-20 | 2011-06-15 | 김춘기 | 돼지족발과 제피를 이용한 건강 보조 식품 제조 방법 및 그 조성물 |
DE102010055170A1 (de) | 2010-12-20 | 2012-06-21 | Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh | Verfahren zur Herstellung alkoholfreier Zusammensetzungen auf pflanzlicher Basis sowie auf diese Weise hergestellte Zusammensetzungen und deren Verwendung |
RU2466735C2 (ru) * | 2011-02-24 | 2012-11-20 | Общество с ограниченной ответственностью "ДИНАМИК ДЕВЕЛОПМЕНТ ЛАБОРАТОРИЗ" | Средство для лечения синдрома хронической усталости, повышения работоспособности, лечения и профилактики острых респираторных вирусных инфекций |
CN102258614B (zh) * | 2011-07-15 | 2013-09-18 | 青岛绿曼生物工程有限公司 | 一种治疗鸡白痢和慢性呼吸道病的复方蜂胶组合物及其制备方法 |
CN102579916B (zh) * | 2012-03-16 | 2013-07-17 | 范冬锁 | 一种治疗呼吸道、消化道癌症的胶囊及其制备方法 |
CN102698233A (zh) * | 2012-06-14 | 2012-10-03 | 何本阳 | 治疗寒饮夹热型小儿毛细支气管炎的中药合剂及制备方法 |
US9913869B2 (en) | 2012-10-17 | 2018-03-13 | Montero Gida Sanayi Ve Ticaret A.S. | Formulations comprising herbal extracts |
SI2908834T1 (sl) | 2012-10-17 | 2017-12-29 | Montero Gida Sanayi Ve Ticaret A.S. | Nove formulacije, ki obsegajo rastlinske ekstrakte |
WO2014060525A1 (en) | 2012-10-18 | 2014-04-24 | Montero Gida Sanayi Ve Ticaret A.S. | Stable formulations |
-
2013
- 2013-10-17 PL PL13786441T patent/PL2908831T3/pl unknown
- 2013-10-17 PT PT137864419T patent/PT2908831T/pt unknown
- 2013-10-17 EP EP13786441.9A patent/EP2908831B1/en active Active
- 2013-10-17 HU HUE13786441A patent/HUE038237T2/hu unknown
- 2013-10-17 TR TR2018/02779T patent/TR201802779T4/tr unknown
- 2013-10-17 LT LTEP13786441.9T patent/LT2908831T/lt unknown
- 2013-10-17 ES ES13786441.9T patent/ES2661373T3/es active Active
- 2013-10-17 EA EA201590571A patent/EA201590571A1/ru unknown
- 2013-10-17 RS RS20180259A patent/RS56980B1/sr unknown
- 2013-10-17 DK DK13786441.9T patent/DK2908831T3/da active
- 2013-10-17 US US14/436,349 patent/US10111912B2/en not_active Expired - Fee Related
- 2013-10-17 WO PCT/EP2013/071758 patent/WO2014060533A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
US10111912B2 (en) | 2018-10-30 |
WO2014060533A1 (en) | 2014-04-24 |
PL2908831T3 (pl) | 2018-07-31 |
TR201802779T4 (tr) | 2018-03-21 |
EA201590571A1 (ru) | 2015-09-30 |
US20150290253A1 (en) | 2015-10-15 |
EP2908831B1 (en) | 2017-12-06 |
LT2908831T (lt) | 2018-03-26 |
PT2908831T (pt) | 2018-03-09 |
RS56980B1 (sr) | 2018-05-31 |
EP2908831A1 (en) | 2015-08-26 |
ES2661373T3 (es) | 2018-03-28 |
HUE038237T2 (hu) | 2018-10-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK2908831T3 (da) | Urteformuleringer | |
US9913869B2 (en) | Formulations comprising herbal extracts | |
DK2908834T3 (da) | Hidtil ukendte formuleringer med planteekstrakter | |
WO2019209227A2 (en) | Solid oral formulations comprising herbal extracts | |
US9907824B2 (en) | Stable formulations | |
CN105848664A (zh) | 用于治疗持续性咳嗽的组合物 | |
Dai et al. | Honey in traditional Chinese medicine: A guide to future applications of NADES to medicines | |
Almekhlafi et al. | Antimicrobial activity of Yemeni myrrh mouthwash | |
WO2019209228A2 (en) | Solid oral compositions comprising dried honey and herbal extracts | |
CN109464540A (zh) | 一种缓解口腔及咽喉不适的喷雾剂及其制备方法 | |
IT201800010002A1 (it) | Composizione fitoterapiche utili per migliorare la qualita' del sonno e nel trattamento dell'insonnia, dell'ansia, della depressione. | |
FR3070261A1 (fr) | Produit de combinaison pour soulager les symptomes lies aux infections des voies respiratoires superieures | |
RU2411954C2 (ru) | Сбор для лечения туберкулеза легких | |
RU2311190C1 (ru) | Лечебно-профилактическое средство для молодняка сельскохозяйственных животных и способ профилактики и лечения вирусных респираторных болезней телят с его применением | |
CN104491359A (zh) | 一种治疗口腔溃疡、咽炎肿痛的中药组合物及其制备方法 | |
Sagar et al. | Formulation and Evaluation of Garlic Gel for Tongue Ulcer | |
CN110448622B (zh) | 治疗热性感冒的药物及其制备方法和应用 | |
WO2022108540A1 (en) | An herbal oral composition comprising natural ingredients | |
Cooke | What is the Cashew Tree? | |
CN114177220A (zh) | 人参与连翘的组合物及其抗病毒等药用 | |
CN113101331A (zh) | 一种百里香药茶及其制备方法和应用 | |
CN105434957A (zh) | 一种含有艾叶的治疗口腔炎症的中药制剂及其制备方法 | |
EA026106B1 (ru) | Иммуностимулирующий фитосбор с общеукрепляющим действием | |
PL234024B1 (pl) | Preparat wspomagający leczenie schorzeń górnych dróg oddechowych i wzmacniający naturalną odporność organizmu |